Hansen Medical Announces 2014 First Quarter Results Conference Call
26 4월 2014 - 6:20AM
Marketwired
Hansen Medical Announces 2014 First Quarter Results Conference Call
MOUNTAIN VIEW, CA--(Marketwired - Apr 25, 2014) - Hansen
Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular
robotics, today announced that it will release its financial and
operating results for the first quarter ended March 31, 2014 after
market close on Wednesday, May 7, 2014.
Chris Lowe, President and Interim Chief Executive Officer, and
Peter Mariani, Chief Financial Officer, will host a conference call
at 5:00 p.m. ET (2:00 p.m. PT) on May 7, 2014 to discuss the
company's results. The call may be accessed by dialing
888-846-5003, or 480-629-9856 for international callers, and
referencing the participant code 4681413. The Company will also
provide a live webcast of the call. Interested participants may
access the webcast on the Investor Relations page of the Company's
website, www.hansenmedical.com. Please go to the website at least
15 minutes early to register, download and install any necessary
audio software.
For those unable to participate in the live broadcast, a replay
will be available two hours after the call ends through Wednesday,
May 14, 2014, at 877-870-5176 or 858-384-5517 for international
callers, access code 4681413. A replay of the call will be archived
on the Investor Relations page of the Company's website.
About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, California, is a
global leader in intravascular robotics, developing products and
technology designed to enable the accurate positioning,
manipulation and control of catheters and catheter-based
technologies. The Company's Magellan™ Robotic System, 9Fr Magellan™
Robotic Catheter, Magellan™ 6Fr Robotic Catheter, and related
accessories are intended to facilitate navigation to anatomical
targets in the peripheral vasculature and subsequently provide a
conduit for manual placement of therapeutic devices. The Magellan
9Fr Robotic Catheter has undergone both CE marking and 510(k)
clearance and is commercially available in the European Union, and
the U.S. The Magellan 6Fr Robotic Catheter has undergone 510(k)
clearance in the U.S. and is in limited release for the next
several months in anticipation of more wide-scale commercially
availability later in 2014. In the European Union, the
Company's Sensei® X Robotic Catheter System and Artisan® and
Artisan Extend® Control Catheters are cleared for use during
electrophysiology (EP) procedures, such as guiding catheters in the
treatment of atrial fibrillation (AF), and the Lynx® Robotic
Ablation Catheter is cleared for the treatment of AF. This robotic
catheter system is compatible with fluoroscopy, ultrasound, 3D
surface map and patient electrocardiogram data. In the U.S., the
Company's Sensei X Robotic Catheter System and Artisan and Artisan
Extend Control Catheters are cleared by the U.S. Food and Drug
Administration for manipulation and control of certain mapping
catheters in EP procedures. In the U.S., the Sensei X Robotic
Catheter System is not approved for use in guiding ablation
procedures; this use remains experimental. The U.S. product
labeling therefore provides that the safety and effectiveness of
the Sensei X Robotic Catheter System and Artisan and Artisan Extend
Control Catheter for use with cardiac ablation catheters in the
treatment of cardiac arrhythmias, including AF, have not been
established. Additional information can be found at
www.hansenmedical.com.
"Artisan Extend," "Hansen Medical," "Hansen Medical (with Heart
Design)," "Heart Design (Logo)," "Sensei," "Lynx," "Artisan,"
"Instinctive Motion," "Fine Force Technology," "IntelliSense" are
registered trademarks, and "Magellan" and "Hansen Medical Magellan"
are trademarks of Hansen Medical, Inc. in the U.S. and other
countries.
Investor Contacts: Peter J. Mariani Chief Financial Officer
Hansen Medical, Inc. 650.404.5800 Westwicke Partners, LLC. Mark
Klausner 443.213.0501 Email Contact Michael Piccinino, CFA
443.213.0509 Email Contact
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024